Clinical trials · San Diego, CA
Angelman Syndrome clinical trials in San Diego
We’re tracking 4 recruiting angelman syndrome studies with a site in or near San Diego — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies near San Diego
- NCT06415344Enrolling by invitationPhase 3
Long-term extension of GTX-102 in Angelman syndrome
This study is a long-term follow-up for people with Angelman syndrome who have already taken part in a GTX-102 trial. It tests whether the treatment continues to be safe and helpful over a longer period.
San Diego, CaliforniaAges Any age - NCT06914609RecruitingPhase 3
Study of ION582 for people with Angelman syndrome
This trial tests a new medicine called ION582 for people with Angelman syndrome. It aims to see if it can help with symptoms and is given as a lumbar puncture (spinal tap). You may be able to join if you have a genetic diagnosis of Angelman syndrome and are between 2 and 50 years old.
San Diego, CaliforniaAges 2–50 - NCT07605429RecruitingPhase 3
Rugonersen treatment for Angelman syndrome
This study tests a new medicine called rugonersen for people with Angelman syndrome. The medicine is given as an injection into the fluid around the spinal cord and may help improve symptoms by targeting the genetic cause of the condition.
San Diego, CaliforniaAges 1–50 - NCT04507997Recruiting
Study of the natural course of Angelman syndrome
This study follows people with Angelman syndrome to understand how their symptoms and development change over time. It may help researchers better describe the condition and support future treatments.
San Diego, CaliforniaAges Any age
Hear when a new Angelman Syndrome trial opens near San Diego, CA
We’ll email you when one opens near San Diego, CA — at most once a week, no account needed, unsubscribe anytime.
Angelman Syndrome trials in other cities
Where these studies are running near San Diego
Institutions with a site for the recruiting angelman syndrome studies listed above.
- Rady Children's Hospital San Diego · 4 studies
What taking part in a angelman syndrome study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting angelman syndrome studies in California.
Common questions
- Are there angelman syndrome clinical trials near San Diego?
- Yes. We're currently tracking 4 recruiting angelman syndrome studies with a site near San Diego, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a angelman syndrome study near San Diego?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in San Diego to take part?
- Not necessarily. These studies have a site near San Diego, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a angelman syndrome trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New angelman syndrome studies open near San Diego regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.